13D/13G Filings - Aimmune Therapeutics Inc. (AIMT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:14 pm
Sale
2020-12-3113GAIMMUNE THERAPEUTICS INC
AIMT
Palo Alto Investors LLC0
0.000%
-3,380,441decrease
(Position Closed)
Filing
History
2020-10-13
10:48 am
Sale
2020-10-1313DAIMMUNE THERAPEUTICS INC
AIMT
Societe des Produits Nestle S.A.100
100.000%
-12,813,147decrease
(-100.00%)
Filing
History
2020-08-31
06:47 am
Purchase
2020-08-3113DAIMMUNE THERAPEUTICS INC
AIMT
Societe des Produits Nestle S.A.12,813,247
19.600%
12,813,247increase
(New Position)
Filing
History
2020-04-24
4:30 pm
Unchanged
2020-04-2213DAIMMUNE THERAPEUTICS INC
AIMT
Nestle Health Science US Holdings Inc.12,727,113
19.600%
0
(Unchanged)
Filing
History